2-Methyltryptamine - CAS 2731-06-8
Catalog: |
BB019524 |
Product Name: |
2-Methyltryptamine |
CAS: |
2731-06-8 |
Synonyms: |
2-(2-methyl-1H-indol-3-yl)ethanamine; 2-(2-methyl-1H-indol-3-yl)ethanamine |
IUPAC Name: | 2-(2-methyl-1H-indol-3-yl)ethanamine |
Description: | 2-Methyltryptamine (CAS# 2731-06-8) is a useful research chemical. |
Molecular Weight: | 174.24 |
Molecular Formula: | C11H14N2 |
Canonical SMILES: | CC1=C(C2=CC=CC=C2N1)CCN |
InChI: | InChI=1S/C11H14N2/c1-8-9(6-7-12)10-4-2-3-5-11(10)13-8/h2-5,13H,6-7,12H2,1H3 |
InChI Key: | CPVSLHQIPGTMLH-UHFFFAOYSA-N |
Boiling Point: | 353 °C at 760 mmHg |
Density: | 1.126 g/cm3 |
Appearance: | Light yellow powder |
LogP: | 2.67780 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112341380-A | Small molecule immunomodulator and application thereof | 20201104 |
CN-111948197-A | Colorimetric card for color development test of novel psychoactive substance and design method thereof | 20200729 |
WO-2021170719-A1 | Process for the preparation of panobinostat | 20200227 |
CN-110437126-A | Organic catalysis indoles disactivation sp3The method and application of C-H bond asymmetry function dough | 20190711 |
CN-110437126-B | Organocatalytic indole non-activated sp3Method and application for asymmetric functionalization of carbon-hydrogen bond | 20190711 |
PMID | Publication Date | Title | Journal |
25870032 | 20150501 | Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide | European journal of clinical pharmacology |
22672791 | 20121101 | Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia | Journal of electrocardiology |
22941032 | 20121101 | CYP2D6 genotype affects age-related decline in flecainide clearance: a population pharmacokinetic analysis | Pharmacogenetics and genomics |
22985507 | 20121018 | Spinal blockades of class I antiarrythmic drugs with bupivacaine by isobolographic analysis in rats | Neuroscience letters |
22764151 | 20120901 | Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency | Cardiovascular research |
Complexity: | 170 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 174.115698455 |
Formal Charge: | 0 |
Heavy Atom Count: | 13 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 174.115698455 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 41.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.8 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Indoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS